Mr. Speaker, creating a four-month interval between the first and second doses of the Pfizer vaccine means the government is now advising an off-label use of the vaccine schedule. Could promoting an off-label use of the vaccine have contractual obligations for Canada's deal with Pfizer?
In the House of Commons on March 11th, 2021. See this statement in context.